Sono-Tek Q4 revenue rises on medical sector growth

Sono-Tek

28/05/2026 12:08

Overview
Ultrasonic coating systems maker's fiscal Q4 revenue rose 10% yr/yr to $5.6 mln
Fiscal Q4 net income increased 70% yr/yr, reflecting margin expansion and higher profitability
Company expects continued revenue growth in 1H FY 2027, led by medical sector demand

Outlook
Sono-Tek anticipates continued revenue growth and profitability in 1H FY 2027
Company projects FY 2027 revenue to be flat to modestly higher versus FY 2026
Company sees uncertainty in clean energy sectors and timing of high-ASP orders

Result Drivers
MARGIN EXPANSION - Gross margin rose due to a favorable product mix with more high-ASP systems and increased U.S. sales, per CEO Steve Harshbarger
MEDICAL SECTOR GROWTH - Strong demand for balloon catheter and stent coating systems drove medical market sales higher
CLEAN ENERGY DECLINE - Lower electrolysis-related orders due to government policy changes weighed on alternative energy sales

Company press release: ID:nGNX5pQnCh

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Revenue
Miss
$5.6 mln
$5.61 mln (2 Analysts)
Q4 EPS
Beat
$0.11
$0.03 (2 Analysts)
Q4 Gross Margin
 
50.00%
 

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the industrial machinery & equipment peer group is "buy"
Wall Street's median 12-month price target for Sono-Tek Corp is $6.75, about 27.1% above its May 27 closing price of $5.31
The stock recently traded at 42 times the next 12-month earnings vs. a P/E of 33 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)